Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. [Phase 2]
Pfizer's Phase 2 trial of sisunatovir in infants with respiratory syncytial virus lower respiratory tract infection has been terminated, wit…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV) [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, and antiviral activity of RV299 against Respiratory Syncytial Virus. The trial is complet…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Safety and Efficacy of BARS13 in the Elderly [Phase 2]
Phase 2 trial evaluating the safety and efficacy of BARS13 in elderly participants with respiratory syncytial virus infections has completed…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants [Phase 1]
Pfizer completed a Phase 1 trial evaluating the safety, effects and palatability of Sisunatovir in healthy adults, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Development of a Human Model of Respiratory Syncytial Virus Infection [NA]
This clinical trial update describes the development of a human model of Respiratory syncytial virus infection; the trial is completed and r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue [NA]
A completed clinical trial comparing early versus rescue initiation of high-flow nasal cannula therapy in infants with bronchiolitis due to …
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult [Phase 1]
Phase 1 study to evaluate the safety, immunogenicity, and pharmacokinetics of GR2102 in healthy adults for respiratory syncytial virus infec…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract [Phase 2]
Phase 2 trial evaluating EDP-938 for respiratory syncytial virus infection in hematopoietic cell transplant recipients with upper respirator…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults [Phase 2]
Phase 2 study evaluating RSVpreF vaccination with an RSV challenge in healthy adults has completed, and results were posted on 2024-08-07.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive [Phase 1]
A Phase 1 dose-escalation study evaluating safety, reactogenicity, and immunogenicity of the mRNA-1345 RSV vaccine in healthy adults and RSV…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
A completed clinical trial evaluating the impact of nirsevimab on emergency department use for bronchiolitis associated with Respiratory Syn…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: RSV Vaccine Pregnancy Registry
Clinical trial update announcing recruitment for a respiratory syncytial virus (RSV) vaccine pregnancy registry sponsored by CorEvitas.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Disease Burden of RSV [NA]
Clinical trial update reporting completion of a study on the disease burden of respiratory syncytial virus infection. The study was conducte…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Infection Watch Study
Duke University's Infection Watch Study has completed, investigating infections caused by COVID-19, respiratory syncytial virus, rhinovirus,…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: A Study of TNM001 in Chinese Healthy Preterm and Term Infants [Phase 1, Phase 2]
A Phase 1/2 study of TNM001 in healthy Chinese preterm and term infants has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers [Phase 1, Phase 2]
This entry reports the completion and results posting of a Phase 1/2 study evaluating Sanofi Pasteur's live-attenuated respiratory syncytial…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Pharmacokinetics and Safety of RV521 Formulations [Phase 1]
Pfizer completed a Phase 1 pharmacokinetics and safety evaluation of RV521 formulations for Respiratory Syncytial Virus Infection.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant [Phase 1, Phase 2]
A Phase 1/2 study of ALVR106 in patients with respiratory tract viral infections after hematopoietic cell or solid organ transplantation was…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants
A completed study investigating molecular and microbiome/metagenome correlates of recurrent wheeze after Respiratory Syncytial Virus infecti…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) [Phase 2]
Phase 2 RSV human challenge study MK-4482-017 in healthy participants has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of the RSV monoclonal antibody RSM01 in healthy adults has completed wit…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Project STARFISH - PRJ0002679
Clinical trial update for Project STARFISH (PRJ0002679) indicates the study has completed. The trial investigated SARS-CoV-2 infection, Infl…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above [Phase 3]
Phase 3 study evaluating safety and immune response of an RSV vaccine when given alone or together with an influenza vaccine in adults aged …
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and immunogenicity of STR-V003 RSV vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older [Phase 3]
Phase 3 study of the Ad26.RSV.preF vaccine for preventing lower respiratory tract disease due to respiratory syncytial virus in adults 60 an…